Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT06442397

Anti-Inflammatory Lifestyle Intervention for Emerging Adult Cancer Survivors

Feasibility and Acceptability of an Anti-Inflammatory Lifestyle Intervention for Emerging Adult Cancer Survivors

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Virginia Commonwealth University · Academic / Other
Sex
All
Age
18 Years – 29 Years
Healthy volunteers
Not accepted

Summary

To test the feasibility and acceptability of AILI and associated research procedures among emerging adult cancer survivors (EACS, N=16) age 18-29.

Detailed description

This is a single-arm pilot trial designed to assess the feasibility and acceptability of an anti-inflammatory lifestyle intervention (AILI) for emerging adults (EA) adapted for emerging adult cancer survivors (EACS).

Conditions

Interventions

TypeNameDescription
BEHAVIORALAnti-Inflammatory Lifestyle InterventionContent includes training in empirically-supported strategies to improve psychological function (e.g., restructuring negative thoughts, distress tolerance), with a focus on changing discrete behaviors linked to inflammation (e.g., sleep, processed foods, physical activity), all intertwined with evidence-based behavior change content adapted to meet the needs of EACS. Participants will also receive digital tools to facilitate daily self-monitoring (Fitbit activity monitor, wireless scales, self-monitoring app) and generate information for tailored weekly e-coaching

Timeline

Start date
2024-10-30
Primary completion
2025-07-31
Completion
2025-07-31
First posted
2024-06-04
Last updated
2025-08-20

Source: ClinicalTrials.gov record NCT06442397. Inclusion in this directory is not an endorsement.